跳至主要内容
临床试验/NCT00539110
NCT00539110已完成2 期

Differential Effects of Zolpidem Versus Ramelteon on Nocturnal Sleep in Pediatric Burn Patients: A Prospective, Randomized Crossover Trial With Polysomnographic Recordings

Shriners Hospitals for Children1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2009年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
10
试验地点
1
主要终点
Polysomnography Data

研究概览

简要总结

To examine sleep changes following therapeutic drug interventions designed to promote sleep.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Burn injury > 20% total body surface area
  • Between 3 and 18 years of age
  • < 7 days from acute injury
  • Written informed consent and HIPPA release signed

排除标准

  • Suspected anoxic brain injury or head injury
  • Hepatic or endocrine disease
  • History of alcoholism or substance abuse
  • Pre-existing neurological or primary psychiatric disorder
  • Medical history of pre-existing sleep disorder or lactose deficiency
  • Questionable survival (<72 hrs) as decided by PI
  • Receipt of drugs with known effects on sleep within 24 hrs of study entry
  • No informed consent/HIPPA release

研究组 & 干预措施

zolpidem

Experimental

zolpidem or ramelteon dosed at 2200 and 0200 per feeding tube depending on randomization

干预措施: zolipidem (Drug)

ramelteon

Active Comparator

ramelteon or zolpidem dosed at 2200 and 0200 per the feeding tube depending on randomization

干预措施: ramelteon (Drug)

结局指标

主要结局

Polysomnography Data

时间窗: 2 weeks postburn

Determine if intervention product elicits more total sleep time

次要结局

  • Pharmacokinetics(2 weeks postburn)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Gottschlich

Director, Nutrition Services

Shriners Hospitals for Children

研究点 (1)

Loading locations...

相似试验